Piloting post-exposure prophylaxis in Kenya raises specific concerns for the management of childhood rape

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 100, Issue 1, 2006, Pages 14-18

  Speight, C G ^a   Klufio, A ^b   Kilonzo, S N ^a   Mbugua, C ^a   Kuria, E ^c   Bunn, J E ^b   Taegtmeyer, Miriam ^a,b  

^a Liverpool VCT   (Kenya)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c Thika District Hospital   (Kenya)

Author keywords

HIV; Lamivudine; Post exposure prophylaxis; VCT; Zidovudine

Indexed keywords

LAMIVUDINE; ZIDOVUDINE;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; CHILD SEXUAL ABUSE; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PILOT STUDY; QUANTITATIVE ANALYSIS; RAPE; RURAL AREA;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BODY WEIGHT; CHILD; CHILD ABUSE, SEXUAL; CHILD, PRESCHOOL; FEASIBILITY STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; KENYA; LAMIVUDINE; MALE; PILOT PROJECTS; PRACTICE GUIDELINES; RAPE; RISK FACTORS; RURAL HEALTH; SEXUALLY TRANSMITTED DISEASES; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 28244462510     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.06.026     Document Type: Article

References (17)

1. J.D. Bamberger C.R. Waldo J.L. Gerberding M.H. Katz Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault Am. J. Med. 106 1999 323-326
2. D.M. Cardo D.H. Culver C.A. Ciesielski P.U. Srivastava R. Marcus D. Abiteboul J. Heptonstall G. Ippolito F. Lot P.S. McKibben D.M. Bell A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group N. Engl. J. Med. 337 1997 1485-1490
3. Government of Kenya National AIDS Control Council. Mainstreaming Gender in the National HIV/AIDS Strategic Plan 2000-2005 2002 Office of the President Nairobi
4. Government of Kenya, 2004. Demographic and Health Survey, 2003. Central Bureau of Statistics, Ministry of Planning and National Development. http://www.cbs.go.ke/kdhs2003.html [accessed 1 April 2004].
5. T. Johnston Gender Series: Violence and Abuse of Women and Girls in Kenya; a Briefing Book. Population Communication Africa, Ford Foundation and CIDA 2002 New World Printer Nairobi
6. J.O. Kahn J.N. Martin M.E. Roland J.D. Bamberger M. Chesney D. Chambers K. Franses T.J. Coates M.H. Katz Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP Study J. Infect. Dis. 183 2001 707-714
7. N. Kilonzo S. Theobald S. Molyneux M. Taegtmeyer Post rape services in Kenya: A situation analysis 2003 Liverpool VCT Centre Nairobi
8. J.C. Kim L. Denny L. Martin Rape and HIV post-exposure prophylaxis: addressing the dual epidemics in South Africa Reprod. Health Matters 11 2003 101-112
9. U. Kistner Rape and Post Exposure Prophylaxis in South Africa: A Review 2003 Centre for AIDS Development, Research and Evaluation (CADRE) South Africa
10. U. Kistner U. Fox W. Parker Child Sexual Abuse and HIV/AIDS in South Africa: A Review 2004 Centre for AIDS Development, Research and Evaluation (CADRE) South Africa
11. S.L. Martin S. Curtis Gender-based violence and HIV/AIDS: Recognising links and acting on the evidence Lancet 363 2004 9419
12. NASCOP, 2004a. Kenyan National ARV Guidelines. National AIDS and STD Control Programme, Ministry of Health, Nairobi.
13. NASCOP, 2004b. Kenyan National Clinical Manual for ARV Providers. National AIDS and STD Control Programme, Ministry of Health, Nairobi.
14. NASCOP, 2005. Kenyan National Clinical Guidelines for the Management of Rape/Sexual Violence. National AIDS and STD Control Programme, Ministry of Health, Nairobi.
15. K.A. Sepkowitz P. Rivera J. Louther S. Lim B. Pryor Postexposure prophylaxis for human immunodeficiency virus: Frequency of initiation and completion of newly recommended regimen Infect. Control Hosp. Epidemiol. 19 1998 506-508
16. M. Sharland G. Castelli Gattinara di Zub J. Tomas Ramos S. Blanche D.M. Gibb on behalf of the PENTA Steering Committee PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Paediatric European Network for Treatment of AIDS HIV Med. 3 2002 215-226
17. UNICEF, 1989. Convention on the Rights of the Child. http://www.unicef.org/crc [accessed 12 March 2004].